BioSenic Stock: price and insider trades · Belgium

BioSenic, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to FSMA. The last twelve months, up to 18 October 2026, brought 10 filings signed by 8 insiders.

No insider sold shares on the market over the period. Instead, the filings list 10 purchases totalling €342k, made by 8 insiders. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 8 board members. At €75k, the purchase published on 15 April 2026 by Finsys Management is the largest of the period.

Across the 77 companies tracked on its exchange, the median is 11 filings; at 10 filings, this issuer sits below that mark. The full history, which starts in 2022, counts 14 purchases against 31 sales.

In all, 10 purchases were made within 30 days of a purchase by another insider of the company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The latest purchase dates back some time: it was published 186 days ago, on 15 April 2026. The median gap between a trade and its publication by FSMA is 5 days. The legal deadline for notifying a trade is three business days (MAR article 19).

For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from FSMA. Past trades are no guide to future returns.